Literature DB >> 1086110

[Von Willebrand-Jürgens syndrome with a variant of factor VIII-associated antigen].

D Böttcher, K Hasler, A H Sutor, D Mair.   

Abstract

A family is described in which 5 out of 8 children had a marked bleeding disorder. The children showed prolonged bleeding times, abnormal platelet retention upon passage of blood through a glass bead column, the Willebrand factor activity as measured by ristocetin in a washed platelet system was low. Factor VIII/von Willebrand factor protein levels were normal even so the factor VIII-procoagulant activity. Even the parents and one child without any bleeding tendency and normal bleeding times had a reduced Willebrand factor activity. In all these patients evidence of an abnormal protein was observed on crossed antigen-antibody electrophoresis indicating a qualitative defect of the factor VIII/von Willebrand factor protein.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086110     DOI: 10.1007/bf01005210

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  18 in total

1.  Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.

Authors:  D Meyer; C S Jenkins; M D Dreyfus; E Fressinaud; M J Larrieu
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

2.  Letter: 8-related antigen and von Willebrand factor.

Authors:  B Firkin; J Koutts
Journal:  Lancet       Date:  1974-04-27       Impact factor: 79.321

3.  Von Willebrand's disease type B: a newly defined bleeding diathesis.

Authors:  B Firkin; F Firkin; L Stott
Journal:  Aust N Z J Med       Date:  1973-06

4.  Platelet adhesiveness in von Willebrand's disease. A study with a new modification of the glass bead filter method.

Authors:  A J Hellem
Journal:  Scand J Haematol       Date:  1970

5.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

6.  Quantitative immunoelectrophoresis of human serum proteins.

Authors:  H G Clarke; T Freeman
Journal:  Clin Sci       Date:  1968-10       Impact factor: 6.124

7.  Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.

Authors:  H R Gralnick; B S Coller; Y Sultan
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

8.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

9.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.

Authors:  H J Weiss; L W Hoyer; F R Rickles; A Varma; J Rogers
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  1 in total

1.  [A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].

Authors:  K Hasler; D Böttcher; R Engelhardt
Journal:  Blut       Date:  1979-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.